Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
Fixed Capital/Sales

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

NEULAND LABORATORIES Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.780.650.780.910.82

What is the latest Fixed Capital/Sales ratio of NEULAND LABORATORIES ?

The latest Fixed Capital/Sales ratio of NEULAND LABORATORIES is 0.78 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.78
Mar20240.65
Mar20230.78
Mar20220.91
Mar20210.82

How is Fixed Capital/Sales of NEULAND LABORATORIES Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.78
20.00
Mar2024 0.65
-16.67
Mar2023 0.78
-14.29
Mar2022 0.91
10.98
Mar2021 0.82 -

Other Financial Ratios of NEULAND LABORATORIES


Compare Fixed Capital/Sales ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹16,869.2 Cr -0.2% -10.4% -9.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹410,442.0 Cr 0.5% -1.5% -2.6% Stock Analytics
DIVIS LABORATORIES ₹171,878.0 Cr 5.5% -0.2% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,301.0 Cr 2.1% 2.8% 30.9% Stock Analytics
CIPLA ₹109,030.0 Cr 1.3% -7.9% -6.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,023.0 Cr 2% 4.5% 2.3% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-0.2%

-10.4%

-9.1%

SENSEX

0.5%

0.8%

7.2%


You may also like the below Video Courses